Related references
Note: Only part of the references are listed.Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5
Melody D. Fulton et al.
EPIGENETICS (2022)
Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
Ayad A. Al-Hamashi et al.
ACTA PHARMACEUTICA SINICA B (2021)
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
Dirk Brehmer et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Chemical probes for protein arginine methyltransferases
Alice Shi Ming Li et al.
METHODS (2020)
Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
Yudao Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cellular consequences of arginine methylation
Benjamin M. Lorton et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
A patent review of arginine methyltransferase inhibitors (2010-2018)
Xiao Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q. Bonday et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing
Sarah Gerhart et al.
SCIENTIFIC REPORTS (2018)
Mechanisms and Inhibitors of Histone Arginine Methylation
Melody D. Fulton et al.
CHEMICAL RECORD (2018)
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Pierre-Jacques Hamard et al.
CELL REPORTS (2018)
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
Harshita Shailesh et al.
Oncotarget (2018)
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis
Lindsay M. Webb et al.
JOURNAL OF IMMUNOLOGY (2017)
PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination
Thomas L. Clarke et al.
MOLECULAR CELL (2017)
The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation
S. S. Tarighat et al.
LEUKEMIA (2016)
Methyltransferase inhibitors for modulation of the epigenome and beyond
Matthieu Schapira et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Small Molecule Inhibitors of Protein Arginine Methyltransferases
Hao Hu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
Yanli Jin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon et al.
CELL REPORTS (2016)
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation
Lapo Alinari et al.
BLOOD (2015)
Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation
Jakob Fuhrmann et al.
CHEMICAL REVIEWS (2015)
Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2
Andrea Hadjikyriacou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors
Gang Zhang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Discovery of a Dual PRMT5-PRMT7 Inhibitor
David Smil et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Inhibitors of protein methyltransferases as chemical tools
Minkui Luo
EPIGENOMICS (2015)
Selective Inhibitors of Protein Methyltransferases
H. Uemit Kaniskan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Beyond click chemistry - supramolecular interactions of 1,2,3-triazoles
Benjamin Schulze et al.
CHEMICAL SOCIETY REVIEWS (2014)
Structural biology and chemistry of protein arginine methyltransferases
Matthieu Schapira et al.
MEDCHEMCOMM (2014)
Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs
Surbhi Dhar et al.
SCIENTIFIC REPORTS (2013)
Scintillation Proximity Assay of Arginine Methylation
Jiang Wu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Histone arginine methylation
Alessandra Di Lorenzo et al.
FEBS LETTERS (2011)
Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
Jung-Mao Hsu et al.
NATURE CELL BIOLOGY (2011)
Structural insights into protein arginine symmetric dimethylation by PRMT5
Litao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Arginine/lysine-methyl/methyl switches: biochemical role of histone arginine methylation in transcriptional regulation
Valentina Migliori et al.
EPIGENOMICS (2010)
Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation
Michael Litt et al.
BIOSCIENCE REPORTS (2009)
Arginine methylation regulates the p53 response
Martin Jansson et al.
NATURE CELL BIOLOGY (2008)
Click chemistry as a macrocyclization tool in the solid-phase synthesis of small cyclic peptides
Rushia A. Turner et al.
ORGANIC LETTERS (2007)
Synthesis and biological evaluation of 5′-triazole nucleosides
Lenselot Lee et al.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2006)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable
MR Pawlak et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
